Susceptibility of Stenotrophomonas maltophilia to Moxifloxacin, Trovafloxacin, Ofloxacin and Ciprofloxacin

Hawley, H.B.; Polenakovik, H.M.; Czachor, J.S.; Mueller, S.S.
December 1999
Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p214
Academic Journal
Examines the in vitro susceptibility of clinical isolates of Gram-negative bacterium Stenotrophomonas maltophilia to newer quinolones. Materials and methods; Results.


Related Articles

  • Prevalence of Ciprofloxacin Resistance Among Gram-Negative Bacilli at a Specialist Hospital in Saudi Arabia. Ahmad, Shamweel // Bangladesh Journal of Medical Science;Oct2012, Vol. 11 Issue 4, p317 

    Background: Resistance to antimicrobials of different structural classes including fluoroquinolones has arisen in a multitude of bacterial species both in the community and the hospitals. This may complicate the therapeutic management of infections. Decreased susceptibility to fluoroquinolones...

  • The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea. Kwang Hyun Chung; Dong Ho Lee; Eunhyo Jin; Yuri Cho; Ji Yeon Seo; Nayoung Kim; Sook Hyang Jeong; Jin Wook Kim; Jin-Hyeok Hwang; Cheol Min Shin // Gut & Liver;Nov2014, Vol. 8 Issue 6, p605 

    Background/Aims: Retreatment after initial treatment failure for Helicobacter pylori is very challenging. The purpose of this study was to evaluate the efficacies of moxifloxacincontaining triple and bismuth-containing quadruple therapy. Methods: A total of 151 patients, who failed initial H....

  • Comparative Activity of 7 Quinolones Against Non-Glucose Fermenting Gram-Negative Bacilli Isolated from Cancer Patients. Balakrishnan, M.; Mago, H.; LeBlanc, B.; Rolston, K.V.I. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p190 

    Evaluates the in vitro activity of seven quinolones against non-glucose fermenting Gram-negative bacilli isolated from clinical specimens of cancer patients. Materials and methods; Results.

  • Clinafloxacin Antibacterial Activity. Ednie, L.M.; Jacobs, M.R.; Appelbaum, P.C. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p217 

    Characterizes the in vitro activity of clinafloxacin compared with other quinolones. Results of MIC testing of several ciprofloxacin-susceptible and -resistant strains; Gram-negative nonfermenters that were generally resistant to quinolones.

  • Comparative In Vitro Activity of Grepafloxacin Against Selected Mutants and Clinical Isolates. Soussy, C.J.; Leblanc, F. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p138 

    Evaluates the in vitro activity of grepafloxacin by agar dilution against quinolone-resistant mutants of Gram-negative bacilli and Enterococcus faecalis and their parent strains. Results; Discussion.

  • Effect of Quinolones on Intestinal Ecology. Edlund, C.; Nord, C.E. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p65 

    Quinolones have a selective effect on the normal human intestinal microflora. Published data on 13 different quinolone agents [ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin, lomefloxacin, levofloxacin, sparfloxacin, rufloxacin, sitafloxacin (DU-6859a), gatifloxacin, trovafloxacin...

  • Impact of Fluoroquinolone Administration on the Emergence of Fluoroquinolone-Resistant Gram-Negative Bacilli from Grastrointestinal Flora. Richard, Pascale; Delangle, Marie Helene; Raffi, Francois; Espaze, Eric; Richet, Herve // Clinical Infectious Diseases;1/1/2001, Vol. 32 Issue 1, p162 

    Discusses a study which assessed the risk factors for acquisition of fluoroquinolone-resistant, gram-negative organisms in the gastrointestinal tract of hospitalized patients. Use of fluoroquinolone for the treatment of infections; Methods used; Analysis of risk factors for colonization with...

  • Activities of Quinolones Against Obligately Anaerobic Bacteria. Schaumann, R.; Rodloff, A. C. // Anti-Infective Agents in Medicinal Chemistry;2007, Vol. 6 Issue 1, p49 

    Quinolones are of clinical and scientific interest since their discovery based on the nalidixic acid in the early 1960s. They are based on two types of ring structures, the quinolone nucleus and the naphthyridone nucleus. Nalidixic acid as the first discovered agent is a naphthyridone and has...

  • Clinical Implications of Pharmacokinetics and Pharmacodynamics of Fluoroquinolones. Wispelwey, Brian // Clinical Infectious Diseases;7/15/2005 Supplement, Vol. 41, pS127 

    This review summarizes key data illustrating the clinical importance of pharmacodynamics, particularly among the fluoroquinolone family of antibacterials. Antibacterials are often divided into 2 groups—either time-dependent or concentration-dependent agents—on the basis of their...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics